Insiders · IMNN

IMNN insider transactions

Imunon Inc. (IMNN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IMNN

• 8d
  President and CEO Lindborg Stacy was granted 6,615 shares, increasing direct ownership by 8% to 93,254 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 8d
  Chief Medical Officer Faller Douglas Vincent was granted 3,516 shares, increasing direct ownership by 12% to 33,451 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 8d
  Executive Chairman of Board Tardugno Michael H was granted 7,147 shares, increasing direct ownership by 9% to 82,504 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 8d
  General Counsel and Corp Sec Eylward Susan was granted 2,449 shares and sold $3,993 worth of shares (2,449 units at $1.63) (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Director Pellizzari Christine A was granted 6,934 shares, increasing direct ownership by 85% to 15,076 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Director Dentzer James E was granted 6,934 shares, increasing direct ownership by 46% to 21,897 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Director Fritz Frederick J. was granted 6,934 shares, increasing direct ownership by 49% to 21,031 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Director Braun Donald P was granted 6,180 shares, increasing direct ownership by 66% to 15,499 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  General Counsel and Corp Sec Eylward Susan was granted 2,541 shares and sold $3,977 worth of shares (2,541 units at $1.57) (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Executive Chairman of Board Tardugno Michael H was granted 6,358 shares, increasing direct ownership by 9% to 75,357 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  Chief Medical Officer Faller Douglas Vincent was granted 3,649 shares, increasing direct ownership by 14% to 29,935 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 21d
  President and CEO Lindborg Stacy was granted 5,010 shares, increasing direct ownership by 6% to 86,639 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 35d
  Executive Chairman of Board Tardugno Michael H was granted 4,603 shares, increasing direct ownership by 7% to 68,999 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 35d
  General Counsel and Corp Sec Eylward Susan was granted 2,150 shares and sold $3,830 worth of shares (2,150 units at $1.78) (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 35d
  Chief Medical Officer Faller Douglas Vincent was granted 3,082 shares, increasing direct ownership by 13% to 26,286 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 35d
  President and CEO Lindborg Stacy was granted 4,907 shares, increasing direct ownership by 6% to 81,629 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 49d
  Executive Chairman of Board Tardugno Michael H was granted 4,410 shares, increasing direct ownership by 7% to 64,396 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 49d
  SEC Form 3 filed by new insider Blacher Joshua

  3 - Imunon, Inc. (0000749647) (Issuer)
• 49d
  General Counsel and Corp Sec Eylward Susan was granted 920 shares and sold $1,730 worth of shares (920 units at $1.88) (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 49d
  Chief Medical Officer Faller Douglas Vincent was granted 1,308 shares, increasing direct ownership by 6% to 23,204 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 49d
  President and CEO Lindborg Stacy was granted 2,534 shares, increasing direct ownership by 3% to 76,722 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 57d
  Chief Medical Officer Faller Douglas Vincent was granted 21,896 shares (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 57d
  General Counsel and Corp Sec Eylward Susan was granted 14,696 shares and sold $20,674 worth of shares (11,800 units at $1.75) (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 57d
  Executive Chairman of Board Tardugno Michael H was granted 42,519 shares, increasing direct ownership by 243% to 59,986 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 57d
  President and CEO Lindborg Stacy was granted 67,150 shares, increasing direct ownership by 954% to 74,188 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 63d
  Executive Chairman of Board Tardugno Michael H was granted 4,629 shares, increasing direct ownership by 36% to 17,467 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 63d
  President and CEO Lindborg Stacy was granted 1,803 shares, increasing direct ownership by 34% to 7,038 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 77d
  Executive Chairman of Board Tardugno Michael H was granted 4,089 shares, increasing direct ownership by 47% to 12,838 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 77d
  President and CEO Lindborg Stacy was granted 1,593 shares, increasing direct ownership by 44% to 5,235 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  Executive Chairman of Board Tardugno Michael H was granted 3,484 shares, increasing direct ownership by 66% to 8,749 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  Director Pellizzari Christine A was granted 5,557 shares, increasing direct ownership by 215% to 8,142 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  Director Dentzer James E was granted 11,148 shares, increasing direct ownership by 292% to 14,963 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  Director Braun Donald P was granted 5,011 shares, increasing direct ownership by 116% to 9,319 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  Director Fritz Frederick J. was granted 10,330 shares, increasing direct ownership by 274% to 14,097 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 90d
  President and CEO Lindborg Stacy was granted 1,491 shares, increasing direct ownership by 69% to 3,642 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 217d
  New insider Church Jeffrey Wayne claimed ownership of 26 shares (SEC Form 3)

  3 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by CFO Bragg Kimberly

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Chief Medical Officer Faller Douglas Vincent

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Director Dentzer James E

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 231d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 350d
  President and CEO Lindborg Stacy converted options into 1,667 shares, increasing direct ownership by 87% to 3,584 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  Director Dentzer James E was granted 3,318 shares (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  Director Pellizzari Christine A was granted 2,248 shares (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  Director Braun Donald P was granted 2,040 shares, increasing direct ownership by 120% to 3,747 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  Director Fritz Frederick J. was granted 3,161 shares, increasing direct ownership by 403% to 3,946 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  SEC Form 4 filed by CFO Bragg Kimberly

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 384d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 434d
  New insider Bragg Kimberly claimed ownership of 20,400 shares (SEC Form 3)

  3 - Imunon, Inc. (0000749647) (Issuer)
• 525d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 525d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 525d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)